Showing results (1551-1560 of 2,472) with videos related to

Sort By:
Pageof 248
Techniques in Coloproctology|April 3, 2024
Short-term clinical and manometric outcomes of percutaneous tibial nerve stimulation for faecal incontinence: a large single-centre seriesA O'Connor, C Molyneux, K Foster, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 17, 2018
Design, Synthesis, Evaluation and Computational Studies of Nipecotic Acid-Acetonaphthone Hybrids as Potential Antiepileptic AgentsAnkit Seth, Piyoosh A Sharma, Avanish Tripathi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2006
Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignanciesR A Sharma, W P Steward, C A Daines, et al.
The Journal of Pediatrics|April 6, 1999
Growth during maintenance hemodialysis: impact of enhanced nutrition and clearanceA Tom, L McCauley, L Bell, et al.
Harvard Business Review|December 8, 1996
When an executive defectsA Sharma, I F Kesner, K L Coleman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 1995
Reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to a supraphysiologic glucose concentration is associated with loss of STF-1 transcription factor expressionL K Olson, A Sharma, M Peshavaria, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|November 1, 1996
Perinatal methanol exposure in the rat. I. Blood methanol concentration and neural cell adhesion moleculesS Stern, K Reuhl, S Soderholm, et al.
Physics in Medicine and Biology|April 5, 2018
4D-PET reconstruction using a spline-residue model with spatial and temporal roughness penaltiesGeorge P Ralli, Michael A Chappell, Daniel R McGowan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 26, 2001
Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agentsS M Plummer, K A Hill, M F Festing, et al.
British Journal of Cancer|June 27, 2002
A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancerK J O'Byrne, A L Thomas, R A Sharma, et al.
Pageof 248